Monday, December 23, 2024
HomeTagsDysval

Dysval

Neurocrine Biosciences Announces Regulatory Approval of Dysval (valbenazine) for the Treatment of Tardive Dyskinesia in Japan

Neurocrine Biosciences, Inc. announced that its collaboration partner, Mitsubishi Tanabe Pharma Corporation (MTPC), obtained regulatory approval of DYSVAL® capsules 40 mg (valbenazine) for the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics